Senetek PLC Announces Positive Results From Pyratine-6(TM) Clinical Trial In Patients With Acne Rosacea
Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, announced positive study results from a clinical trial of Pyratine-6(TM) in patients with acne rosacea. The findings have been accepted for presentation at the International Investigative Congress of Dermatology at its May 2008 meeting in Kyoto, Japan.
This post is an original post by ScienceDaily: Skin Care News
Posted: May 6th, 2008 under skin health.
Comments: none
Write a comment